Abstract
Summary
LPI (LP Information)' newest research report, the “AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Industry Forecast” looks at past sales and reviews total world AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia sales in 2022, providing a comprehensive analysis by region and market sector of projected AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia sales for 2023 through 2029. With AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia industry.
This Insight Report provides a comprehensive analysis of the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia.
The global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia players cover Infervision, BlueDot, Yitu Healthcare and SPHCC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Pre-Outbreak Forecast
CT Diagnosis
Other
Segmentation by application
Hospital
Center for Infectious Diseases
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Infervision
BlueDot
Yitu Healthcare
SPHCC
This Insight Report provides a comprehensive analysis of the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia.
The global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia players cover Infervision, BlueDot, Yitu Healthcare and SPHCC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Pre-Outbreak Forecast
CT Diagnosis
Other
Segmentation by application
Hospital
Center for Infectious Diseases
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Infervision
BlueDot
Yitu Healthcare
SPHCC
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2018-2029
2.1.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Segment by Type
2.2.1 Pre-Outbreak Forecast
2.2.2 CT Diagnosis
2.2.3 Other
2.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type
2.3.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023)
2.4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Segment by Application
2.4.1 Hospital
2.4.2 Center for Infectious Diseases
2.4.3 Other
2.5 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application
2.5.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023)
3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Player
3.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Players
3.1.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue by Players (2018-2023)
3.1.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Players (2018-2023)
3.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia by Regions
4.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Regions (2018-2023)
4.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
4.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
4.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
4.5 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
5 Americas
5.1 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2018-2023)
5.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
5.3 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2018-2023)
6.2 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
6.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia by Country (2018-2023)
7.2 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
7.3 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia by Region (2018-2023)
8.2 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
8.3 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Regions (2024-2029)
10.1.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Regions (2024-2029)
10.1.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.1.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.1.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.1.5 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Country (2024-2029)
10.2.1 United States AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.2.2 Canada AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.2.3 Mexico AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.2.4 Brazil AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Region (2024-2029)
10.3.1 China AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.2 Japan AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.3 Korea AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.4 Southeast Asia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.5 India AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.6 Australia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Country (2024-2029)
10.4.1 Germany AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.2 France AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.3 UK AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.4 Italy AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.5 Russia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Region (2024-2029)
10.5.1 Egypt AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.2 South Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.3 Israel AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.4 Turkey AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.5 GCC Countries AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.6 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Type (2024-2029)
10.7 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Infervision
11.1.1 Infervision Company Information
11.1.2 Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.1.3 Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Infervision Main Business Overview
11.1.5 Infervision Latest Developments
11.2 BlueDot
11.2.1 BlueDot Company Information
11.2.2 BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.2.3 BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BlueDot Main Business Overview
11.2.5 BlueDot Latest Developments
11.3 Yitu Healthcare
11.3.1 Yitu Healthcare Company Information
11.3.2 Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.3.3 Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Yitu Healthcare Main Business Overview
11.3.5 Yitu Healthcare Latest Developments
11.4 SPHCC
11.4.1 SPHCC Company Information
11.4.2 SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.4.3 SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 SPHCC Main Business Overview
11.4.5 SPHCC Latest Developments
12 Research Findings and Conclusion